Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: drug manufacturer

drug manufacturer stories: 5 news summaries

 Merck to Buy Schering-Plough 
 in Latest Pharma Merger 

Drug giant's purchase comes weeks after Pfizer-Wyeth merger

Mar 9, 09 6:34 AM CDT
(Newser) - Merck announced today that it will merge with fellow drugmaker Schering-Plough in a $41.1 billion cash-and-stock deal to enlarge its pipeline of new drugs in development, reports the Wall Street Journal. The two companies have already collaborated on cholesterol drug Zetia—whose sales plummeted after a study questioned its... More »

MORE ABOUT:
Merck • mergers and acquisitions • merger • drug manufacturer • Schering-Plough

Feds ID Extra Drug in Baxter's Recalled Heparin

FDA unsure if chemical was behind reactions
to blood-thinner

Mar 19, 08 1:44 PM CDT
(Newser) - The Food and Drug Administration has identified the extra ingredient found in samples of Baxter’s blood-thinning drug heparin, the Wall Street Journal reports today. Some batches of the drug—recalled in January after reports of allergic reactions—contained over-sulfated chondroitin sulfate, but it is not certain that was the... More »

MORE ABOUT:
China • FDA • pharmaceutical companies • Heparin • Baxter International • blood thinner • drug manufacturer • drug recall • allergic reaction • chondroitin sulfate

FDA Finds Contaminant in Blood Thinner

Substance discovered in heparin, linked to
19 deaths nationwide

Mar 5, 08 9:49 PM CST
(Newser) - The FDA has found a contaminant in samples of heparin, a blood thinner produced mainly in China linked to 19 deaths and nearly 800 allergic reactions in the US, the New York Times reports. The contaminant may be a counterfeit form of heparin added to reduce its manufacturing cost. The... More »

MORE ABOUT:
China • FDA • pharmaceutical industry • Heparin • Baxter International • blood thinner • drug manufacturer

FDA Approved Wrong China Firm

Hundreds ill, 4 dead after using heparin from factory never inspected

Feb 19, 08 6:26 AM CST
(Newser) - The Chinese facility that supplied the active ingredient of the blood-thinner heparin, linked to hundreds of adverse reactions and four US deaths, was never inspected by the FDA because the agency confused it with another plant of the same name, the Washington Post reports. The company was given approval based... More »

MORE ABOUT:
China • FDA • blood pressure • Government Accountability Office • inspection • House Energy and Commerce Committee • John Dingell • pharmaceutical industry • Heparin • Baxter International • blood thinner • Changzhou • Joseph Famulare • drug manufacturer • Andrew von Eschenbach

Big Pharma Faces Big Plunge

Profits will drop as patents expire, and chemical-based therapies are eclipsed by biotech

Dec 6, 07 4:50 AM CST
(Newser) - Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic... More »

MORE ABOUT:
Merck • pharmaceutical companies • GlaxoSmithKline • Pfizer • Eli Lilly • Zocor • Lipitor • Plavix • pharmaceutical industry • Zyprexa • Fosamax • Singulair • Cozaar • torcetrapib • drug manufacturer

5 Stories


from our news partners